pancreatic cancer

You have access
BHLHE41 Enhances Gemcitabine Sensitivity of Pancreatic Cancer Cells Through IGFBP4 Suppression
HISAAKI SHII, KENTARO MINAMI, RYU TAKEYA and RYUJI IKEDA

Anticancer Research January 2026, 46 (1) 213-226; DOI: https://doi.org/10.21873/anticanres.17936
You have access
Inter-fractional Variation of Linear Energy Transfer Profiles During Carbon-ion Radiotherapy for Pancreatic Cancer
YUKIHIKO YOSHIMATSU, TAKAHIRO OIKE, MAKOTO SAKAI, YUHEI MIYASAKA, HANAE YOSHIDA and TATSUYA OHNO

Anticancer Research January 2026, 46 (1) 475-485; DOI: https://doi.org/10.21873/anticanres.17961
Open Access
Simultaneous Targeting of Multiple Hallmarks of Cancer With Recombinant Methioninase, Rapamycin and Chloroquine Is Specific and Synergistic to MiaPaCa-2 Pancreatic-Cancer Cells in Contrast to Hs-27 Normal Fibroblasts
JINSOO KIM, QINGHONG HAN, SHUKUAN LI, BYUNG MO KANG, KOHEI MIZUTA, YOHEI ASANO, YUTA MIYASHI, MICHAEL BOUVET and ROBERT M. HOFFMAN

Anticancer Research November 2025, 45 (11) 4765-4770; DOI: https://doi.org/10.21873/anticanres.17825
Open Access
Triple Combination of Recombinant Methioninase and the Anti-parasitic Drugs Ivermectin, and Chloroquine Selectively Eradicates Pancreatic Cancer Cells While Sparing Normal Fibroblasts
YOHEI ASANO, QINGHONG HAN, SHUKUAN LI, KOHEI MIZUTA, BYUNG MO KANG, JIN SOO KIM, YUTA MIYASHI, NORIO YAMAMOTO, KATSUHIRO HAYASHI, HIROAKI KIMURA, SHINJI MIWA, KENTARO IGARASHI, TAKASHI HIGUCHI, SEI MORINAGA, HIROYUKI TSUCHIYA, SATORU DEMURA and ROBERT M. HOFFMAN

Anticancer Research November 2025, 45 (11) 4791-4802; DOI: https://doi.org/10.21873/anticanres.17828
You have access
RFC4 Drives Pancreatic Cancer Progression: Prognostic Relevance and Functional Evidence
JAE WOONG KOH and SEON-JOO PARK

Anticancer Research November 2025, 45 (11) 4909-4920; DOI: https://doi.org/10.21873/anticanres.17814
You have access
Significance of Preoperative Chemotherapy and Chemoradiotherapy in Patients With Locally Advanced and Borderline Resectable Pancreatic Cancer
MASAAKI MURAKAWA, REI KANEMOTO, TATSUYA KANAI, NAOHIKO MATSUSHITA, MARIKO KAMIYA, SATOSHI KOBAYASHI, MAKOTO UENO, KEISUKE KAZAMA, NAOTO YAMAMOTO, TAKASHI OHSHIMA, AYA SAITO and SOICHIRO MORINAGA

Anticancer Research October 2025, 45 (10) 4585-4596; DOI: https://doi.org/10.21873/anticanres.17804
You have access
Risk Factors for Early Recurrence of Resectable Pancreatic Cancer
RYUICHIRO KIMURA, YOSHIHIRO MIYASAKA, KUKIKO NOMA, TAKASHI TANIGUCHI, TOMOKI NAKAFUSA, TAKAHIRO TOMOSUGI, NOBORU IDENO, YASUHISA MORI, KOHEI NAKATA, TAKAO OHTSUKA, TAKEO YAMAMOTO, YOSHINAO ODA and MASAFUMI NAKAMURA

Anticancer Research October 2025, 45 (10) 4441-4452; DOI: https://doi.org/10.21873/anticanres.17792
You have access
Development and Validation of a Nomogram of Predict Eligibility for Second-line Chemotherapy in Pancreatic Cancer
KENTARO SATO, REI SUZUKI, NAOKI KONNO, HIROKI IRIE, KO WATANABE, HIROMICHI IMAIZUMI, YUICHI WARAGAI, MITSURU SUGIMOTO, HIROYUKI ASAMA, HIROSHI SHIMIZU, REI OHIRA and HIROMASA OHIRA

Anticancer Research October 2025, 45 (10) 4509-4518; DOI: https://doi.org/10.21873/anticanres.17798
Open Access
Preoperative Predictive Nomogram (DASINEL Score) for Early Recurrence in Pancreatic Cancer
HIROMITSU MAEHIRA, NOBUHITO NITTA, HARUKI MORI, TAKERU MAEKAWA, TAKESHI SONODA, REIKO OTAKE, SOICHIRO TANI, KATSUSHI TAKEBAYASHI, MASATSUGU KOJIMA, SACHIKO KAIDA, TORU MIYAKE and MASAJI TANI

Anticancer Research September 2025, 45 (9) 3773-3784; DOI: https://doi.org/10.21873/anticanres.17737
You have access
Prediction System for KRAS Mutation Detection in Circulating Tumor DNA in Unresectable Pancreatic Cancer
HIROSHI SHIMIZU, REI SUZUKI, HIROYUKI ASAMA, MITSURU SUGIMOTO, KENTARO SATO, KENTO OSAWA, REI OHIRA and HIROMASA OHIRA

Anticancer Research September 2025, 45 (9) 3931-3938; DOI: https://doi.org/10.21873/anticanres.17751

Main menu

User menu

Search

pancreatic cancer

Pages